Organization
Sunho BioPharmaceutical
10 clinical trials
Clinical trial
Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) and Preliminary Efficacy of IBD0333 in Patients With Locally Advanced/Metastatic Solid Tumor or Non-Hodgkin LymphomaStatus: Not yet recruiting, Estimated PCD: 2029-12-31
Clinical trial
A Phase I/IIa Study of IAH0968 in Patients With HER2-positive Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Phase I/II Clincal Trial of Intravesical IAP0971 in Combination With Bacillus Calmette Guerin (BCG) in Patients With BCG Unresponsive High Risk Non-Muscular Invasive Bladder Cancer (NMIBC)Status: Not yet recruiting, Estimated PCD: 2024-10-07
Clinical trial
A Clinical Trial of Phase Ib/II to Evaluate Effect of IAP0971 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
Phase Ib/II Clinical Study of IAH0968 in Combination With Gemcitabine and Cisplatin for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors and CholangiocarcinomaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
To Evaluate IAH0968 in Combination With CAPEOX in a Phase II/III Clinical Study of HER2-positive Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of IBC0966 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase I/II Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IBB0979 in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of IAP0971 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2024-05-30
Clinical trial
A Phase I/IIa Clinical Trial to Evaluate the Safety,Tolerability,Pharmacokinetics and Preliminary Effectiveness of IAE0972 in Patients With Advanced Malignant Solid Tumors.Status: Recruiting, Estimated PCD: 2024-05-30